The Great Debate: What is Enough... Women in Clinical Trials

Join the FDA Office of Women’s Health for The Great Debate! Featuring Ellis F. Unger, M.D., FDA CDER, and Rita F. Redberg, M.D., M.Sc., F.A.C.C., the debate centers on cardiovascular disease clinical trials and the challenges and complexity of the question “What is enough?”, when determining participation of women in these trials. FDA Commissioner, Scott Gottlieb, M.D., will provide the Keynote in celebration of National Women’s Health Week.